Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.


Latest Press Releases

BioNxt Solutions Inc. Announces Non-Brokered Private Placement of Units
Healthcare & PharmaceuticalCompany Update

BioNxt Solutions Inc. Announces Non-Brokered Private Placement of Units

November 16, 2026 8:05 PM

BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT) is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company (the "Units") at a price of $0.25 per Unit for gross proceeds of up to $2,500,000 (the "Offering"). Each Unit will be comprised of one common share in the capital of the Company (a "Share") and one Share purchase warrant (each whole warrant, a "Warrant"). Each Warrant...

Read more
MagneSleep Reviews and Complaints 2026: Looking Beyond Melatonin? Inside Dr. Love's Five-Form Magnesium Formula
Healthcare & PharmaceuticalAdvertorial

MagneSleep Reviews and Complaints 2026: Looking Beyond Melatonin? Inside Dr. Love's Five-Form Magnesium Formula

November 16, 2026 6:15 PM

Quick heads-up: this is a paid advertorial, so a commission is earned if you buy through the links below, at no extra cost to you. Those links open the brand's own store at enduramind.net. MagneSleep is a dietary supplement, not a drug. It isn't FDA-approved and isn't intended to diagnose, treat, cure, or prevent any disease. Details reflect the brand's label and pages as reviewed in November 2026. MagneSleep Reviews & Complaints: Is the Black...

Read more
ADM Tronics Reports Second Quarter of Fiscal Year 2027 Results
Healthcare & PharmaceuticalEarnings

ADM Tronics Reports Second Quarter of Fiscal Year 2027 Results

November 16, 2026 5:15 PM

ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results for its second fiscal quarter ended September 30, 2026 of Fiscal Year 2027. Revenues for the three months ended September 30, 2026 were $941,671 as compared to $887,498 for the three months ended September 30, 2025, an increase of over 6.1%. Income from operations for the three months ended September...

Read more
Aytu BioPharma Reports Fiscal 2027 First Quarter Operational and Financial Results
Healthcare & PharmaceuticalEarnings

Aytu BioPharma Reports Fiscal 2027 First Quarter Operational and Financial Results

November 16, 2026 4:15 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced operational and financial results for the fiscal 2027 first quarter ended September 30, 2026. Q1 Fiscal 2027 Highlights Net revenue increased 6.9% to $14.8 million versus $13.9 million in Q1 fiscal 2026. EXXUA net...

Read more
Ensysce Biosciences Announces Participation in Upcoming Investor Conferences
Healthcare & PharmaceuticalCompany Update

Ensysce Biosciences Announces Participation in Upcoming Investor Conferences

November 16, 2026 4:15 PM

Ensysce Biosciences, Inc. (NASDAQ:ENSC) ("Ensysce" or the "Company"), a clinical-stage biotechnology company developing novel neuroplastogenic therapies beyond mood disorders, with an initial focus on CRPS (Complex Regional Pain Syndrome), today announced that management of the recently acquired Cy Biopharma Inc., James Morrison, Chief Executive Officer; Roger Sawhney, MD, Chief Financial Officer and Chief Business Officer; and Prof. Richard...

Read more
Rosemont Pharmaceuticals to Acquire Aytu BioPharma in All-Cash Tender Offer
Healthcare & PharmaceuticalMergers and Acquisitions

Rosemont Pharmaceuticals to Acquire Aytu BioPharma in All-Cash Tender Offer

November 16, 2026 4:01 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced that it has entered into a definitive merger agreement with Rosemont Pharmaceuticals Holdings, Inc. ("Rosemont"), pursuant to which Rosemont would acquire Aytu, through a tender offer for $2.70 per share. Under the...

Read more
Bonita Springs Psychiatrist Publishes Three 2026 Papers Proposing a Unified
Healthcare & PharmaceuticalCompany Update

Bonita Springs Psychiatrist Publishes Three 2026 Papers Proposing a Unified "Redox" Framework for Schizophrenia and Neurodegenerative Disease

November 16, 2026 3:55 PM

Leonard A. Lado, MD, RPh, a board-certified psychiatrist and founder of Lado Healing Institute in Bonita Springs, has published three peer-reviewed articles this year that together propose one idea: the brain's capacity to control oxidative stress, which he calls "redox reserve," may be an early, measurable and potentially modifiable factor in schizophrenia, Alzheimer's disease and other central nervous system disorders. The most recent article,...

Read more
Costa Rica Expansion Strengthens the Supply Chain for Rapid PFA Catheter Prototyping
Healthcare & PharmaceuticalCompany Update

Costa Rica Expansion Strengthens the Supply Chain for Rapid PFA Catheter Prototyping

November 16, 2026 11:25 AM

As rapid innovation advances pulsed field ablation (PFA), a catheter-based treatment for atrial fibrillation (AFib) within the cardiac electrophysiology market, Medical Component Specialists (MCS) is gearing up to be a critical link in the supply chain. Traditional catheter ablation uses heat or extreme cold to treat the heart tissue responsible for irregular rhythms. PFA uses targeted electrical pulses, offering the potential to reduce damage...

Read more
SynAct Pharma CEO has Acquired Shares in the Company
Healthcare & PharmaceuticalCompany Update

SynAct Pharma CEO has Acquired Shares in the Company

November 16, 2026 10:50 AM

SynAct Pharma AB (publ) ("SynAct") (Nasdaq Stockholm:SYNACT), a clinical-stage biotechnological company focused on treating inflammation through a novel therapeutic approach known as "pro-resolution", today announced that its CEO, Jeppe Øvlesen, has acquired 20,313 shares in the company. "SynAct has an exciting future ahead, and I am very confident in the potential we are building. My investment reflects my strong belief in the company's...

Read more
Medical Care Technologies Inc. (OTCID:MDCE) Follows Q3 Profit Surge With Confirmed Software Development and Expanding Subsidiary Activity
Healthcare & PharmaceuticalCompany Update

Medical Care Technologies Inc. (OTCID:MDCE) Follows Q3 Profit Surge With Confirmed Software Development and Expanding Subsidiary Activity

November 16, 2026 9:11 AM

Medical Care Technologies Inc. (OTCID:MDCE) today pointed to the commercial activity supporting the profitability improvements reported in its third-quarter results. On November 12, the Company reported unaudited results for the three and nine months ended September 30, 2026. For the third quarter, sales revenue increased 13% to $538,981 from $478,128. Gross profit rose 55% to $240,839 from $155,720. Net operating income increased 254% to...

Read more
Sharecare Integrates IDMe into AskMD, Providing Over 100 Million Americans a Seamless, Secure Way to Access Personalized Health Guidance
Healthcare & PharmaceuticalProduct Announcements

Sharecare Integrates IDMe into AskMD, Providing Over 100 Million Americans a Seamless, Secure Way to Access Personalized Health Guidance

November 16, 2026 9:08 AM

Sharecare, the digital health enablement company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced at HLTH USA 2026 that it has integrated IDMe, the market-leading digital identity wallet, into AskMD by Sharecare. AskMD is an AI-powered health navigation experience that helps people understand what is happening with their health, what to do next, and where to go for care....

Read more
Jaguar Health Reports Third Quarter 2026 Financials
Healthcare & PharmaceuticalEarnings

Jaguar Health Reports Third Quarter 2026 Financials

November 16, 2026 9:00 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today reported its consolidated third-quarter 2026 financial results. 2026 THIRD QUARTER COMPANY FINANCIAL RESULTS: License and Grant Revenue: Effective January 12, 2026, Jaguar entered a U.S. commercial licensing agreement with Woodward Specialty, LLC ("Woodward"), an affiliate of privately held Future Pak, LLC ("Future Pak"). Under the terms of the agreement, Future Pak is now the...

Read more
Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results
Healthcare & PharmaceuticalCompany Update

Aptevo Provides 3Q26 Business Update Highlighting Growing Momentum for Mipletamig and Reports Third Quarter Financial Results

November 16, 2026 8:30 AM

Aptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company developing novel multispecific immuno-oncology therapeutics, today reported financial results for the quarter ended September 30, 2026, and highlighted new clinical findings supporting mipletamig's potential in frontline acute myeloid leukemia (AML), progress in optimizing treatment tolerability, and continued advancement of its next-generation cancer treatment...

Read more
Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia
Healthcare & PharmaceuticalPartnerships

Sharecare Partners With HomeTown Health to Bring AskMD, Funded Through the GREAT Health Program, to More Rural Hospitals and Patients Across Georgia

November 16, 2026 8:30 AM

Sharecare, the digital health enablement company that helps to improve care quality, drive better outcomes, and lower costs across the healthcare ecosystem, today announced at HLTH USA 2026 that it has been named a gold level business partner of HomeTown Health, an organization of rural and small hospitals that work together to find ways to survive and thrive in a complex healthcare environment. The partnership follows Sharecare's selection by...

Read more
CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline
Healthcare & PharmaceuticalEarnings

CNS Pharmaceuticals Reports Third Quarter 2026 Financial Results and Highlights Progress in Establishing Transformative Therapeutic Pipeline

November 16, 2026 7:30 AM

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today reported financial results for the third quarter ended September 30, 2026 and provided an update on its corporate strategy. CNS Pharmaceuticals continues to make meaningful progress in executing its pipeline expansion strategy, advancing discussions with...

Read more
OBI Pharma Signs Collaboration and License Agreement with Novartis
Healthcare & PharmaceuticalPartnerships

OBI Pharma Signs Collaboration and License Agreement with Novartis

November 16, 2026 3:10 AM

OBI Pharma, Inc. (4174.TWO) ("OBI") announced that it has entered into a Collaboration and License agreement with Novartis Pharma AG ("Novartis") to develop next generation Antibody-Drug-Conjugates (ADCs) with novel payloads, using OBI's suite of platform technologies. Under the terms of the agreement, Novartis will receive worldwide rights to OBI's related patents and know-how using its ADC platform technologies on an exclusive basis for...

Read more
Sten Sörensen resign from Board of Directors of SynAct Pharma
Healthcare & PharmaceuticalCompany Update

Sten Sörensen resign from Board of Directors of SynAct Pharma

November 16, 2026 1:25 AM

SynAct Pharma (STO:SYNACT) - SynAct Pharma AB (publ) ("SynAct") announced today Sten Sörensen has notified the Board of his decision to resign as a member of the Board to focus on his executive responsibilities. "We are grateful for Sten's time and commitment to the Board. He has been a valuable member of the Board during an important period for SynAct, and we greatly appreciate his contributions and insights. We wish him every success in his...

Read more
Attorney General Rescheduling Order Claimed State Marijuana Controls Were Robust. Oklahoma Law Enforcement Tells a Different Story
Healthcare & PharmaceuticalCompany Update

Attorney General Rescheduling Order Claimed State Marijuana Controls Were Robust. Oklahoma Law Enforcement Tells a Different Story

November 15, 2026 5:00 PM

MMJ International Holdings, Inc. ("MMJ"), a pharmaceutical cannabinoid developer pursuing U.S. Food and Drug Administration (FDA)-regulated treatments for Huntington's disease and multiple sclerosis, is raising serious questions about the factual foundation of the Attorney General's April 28, 2026 marijuana rescheduling order following new testimony from Oklahoma law enforcement officials describing extensive failures within that state's medical...

Read more
Action Behavior Centers BCBAs and Teammates Volunteer Across San Antonio, Donating 271 Pounds of Food During First Hands In Week
Healthcare & PharmaceuticalCompany Update

Action Behavior Centers BCBAs and Teammates Volunteer Across San Antonio, Donating 271 Pounds of Food During First Hands In Week

November 13, 2026 3:00 PM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), announced the successful completion of its inaugural San Antonio Hands In Week, held November 2-7, 2026. Over six days, ABC clinical and center teammates filled 50 volunteer spots across Bexar County and collected 271 pounds of food to support local families experiencing food...

Read more
Phoenix ABA Therapy Provider Action Behavior Centers Delivers Largest Donation in Jose's Closet History During Second Arizona Hands In Week
Healthcare & PharmaceuticalCompany Update

Phoenix ABA Therapy Provider Action Behavior Centers Delivers Largest Donation in Jose's Closet History During Second Arizona Hands In Week

November 13, 2026 2:15 PM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), completed its second Arizona Hands In Week, held November 2-7, 2026. Board Certified Behavior Analysts® (BCBAs®) and center teammates across the Phoenix area filled 35 volunteer spots with four local partners. ABC families and teammates also donated clothing, diapers, and other...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers • July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie • July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers • July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers • June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers • June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers • June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?